GRAYBUG

graybug-logo

GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro โ€“ and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.

#SimilarOrganizations #People #Financial #Website #More

GRAYBUG

Social Links:

Industry:
Biotechnology Health Care Medical Wellness

Founded:
2011-01-01

Address:
Baltimore, Maryland, United States

Country:
United States

Website Url:
http://www.graybug.vision

Total Employee:
51+

Status:
Active

Contact:
650-487-2800

Email Addresses:
[email protected]

Total Funding:
129.24 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Pound Sterling Japanese Yen WP Engine


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

edison-pharmaceuticals-logo

Edison Pharmaceuticals

Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.


Current Advisors List

gerald-cagle_image

Gerald Cagle Member of the Board of Directors @ GrayBug
Board_member

gerald-cagle_image

Gerald Cagle Senior Advisor @ GrayBug
Advisor

michael-keyoung_image

Michael Keyoung Board of Directors @ GrayBug
Board_member
2019-08-01

christy-l-shaffer_image

Christy L. Shaffer Chair of the Board, member of the Audit and Corporate Governance/Nominating Committees @ GrayBug
Board_member
2015-03-01

Current Employees Featured

not_available_image

Ming Yang
Ming Yang SVP, Research & Development @ GrayBug
SVP, Research & Development
2021-01-01

julie-eastland_image

Julie Eastland
Julie Eastland Board Member / Audit Committee Chair @ GrayBug
Board Member / Audit Committee Chair
2020-09-01

rajendra-mohabir_image

Rajendra Mohabir
Rajendra Mohabir Vice President Product Development & Alliance Management @ GrayBug
Vice President Product Development & Alliance Management
2017-09-01

justin-hanes_image

Justin Hanes
Justin Hanes Founder, Director & Former CEO @ GrayBug
Founder, Director & Former CEO
2011-05-01

gerald-cagle_image

Gerald Cagle
Gerald Cagle Head of Business Development @ GrayBug
Head of Business Development

Founder


christy-wyskie_image

Christy Wyskie

justin-hanes_image

Justin Hanes

not_available_image

Lewis J.

peter-a-campochiaro_image

Peter A. Campochiaro

not_available_image

Peter J. McDonnell

Stock Details


Company's stock symbol is NASDAQ:GRAY

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - GrayBug

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series C - GrayBug

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Series C - GrayBug

c-bridge-capital_image

C-Bridge Capital

C-Bridge Capital investment in Series C - GrayBug

clarus-ventures_image

Clarus Ventures

Clarus Ventures investment in Series B - GrayBug

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series B - GrayBug

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - GrayBug

deerfield_image

Deerfield

Deerfield investment in Series B - GrayBug

hatteras-venture-partners_image

Hatteras Venture Partners

Hatteras Venture Partners investment in Series A - GrayBug

maryland-venture-fund_image

Maryland Venture Fund

Maryland Venture Fund investment in Series A - GrayBug

Official Site Inspections

http://www.graybug.vision

  • Host name: 199.59.243.227
  • IP address: 199.59.243.227
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "GrayBug" on Search Engine